Report - EvaluatePharma World Preview 2018, Outlook to 2024info.evaluategroup.com/rs/607-YGS-364/images/WP2018.pdf · of only +1.2%, an annual CAGR of +6.4% is forecast for 2018 through 2024,

Please pass captcha verification before submit form